TY - JOUR
T1 - A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
AU - Arık, Sercan
AU - Shor, Joel
AU - Sinha, Rajarishi
AU - Yoon, Jinsung
AU - Ledsam, Joseph R.
AU - Le, Long T.
AU - Dusenberry, Michael W.
AU - Yoder, Nathanael C.
AU - Popendorf, Kris
AU - Epshteyn, Arkady
AU - Euphrosine, Johan
AU - Kanal, Elli
AU - Jones, Isaac
AU - Li, Chun Liang
AU - Luan, Beth
AU - Mckenna, Joe
AU - Menon, Vikas
AU - Singh, Shashank
AU - Sun, Mimi
AU - Ravi, Ashwin Sura
AU - Zhang, Leyou
AU - Sava, Dario
AU - Cunningham, Kane
AU - Kayama, Hiroki
AU - Tsai, Thomas
AU - Yoneoka, Daisuke
AU - Nomura, Shuhei
AU - Miyata, Hiroaki
AU - Pfister, Tomas
N1 - Funding Information:
H.M. and S.N. are recipients of a Google.org Fellowship grant. The remaining authors declare no competing interests.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently <8% (US) and <29% (Japan), while cumulative MAPE remained <2% (US) and <10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions.
AB - The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently <8% (US) and <29% (Japan), while cumulative MAPE remained <2% (US) and <10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions.
UR - http://www.scopus.com/inward/record.url?scp=85116781679&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116781679&partnerID=8YFLogxK
U2 - 10.1038/s41746-021-00511-7
DO - 10.1038/s41746-021-00511-7
M3 - Article
AN - SCOPUS:85116781679
SN - 2398-6352
VL - 4
JO - npj Digital Medicine
JF - npj Digital Medicine
IS - 1
M1 - 146
ER -